Public Release: 

Minneapolis Heart Institute foundation announces schedule of events at TCT conference

Minneapolis Heart Institute Foundation

MINNEAPOLIS, MN - October 18, 2012 - The Minneapolis Heart Institute Foundation today announced its schedule of presentations at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, which runs from October 22-26 at the Miami Beach Convention Center in Miami, FL. The Foundation is represented at TCT 2012 in 24 presentations, live cases, posters and other sessions.

Researchers from the Minneapolis Heart Institute Foundation participate in over 150 clinical trials annually and are represented in over 100 peer-reviewed publications per year. Together with the Minneapolis Heart Institute, Foundation physicians present at over 130 conferences annually.

"We are pleased to bring robust clinical data and new insights to TCT in 2012 and look forward to working with the Cardiovascular Research Foundation to bring new perspectives, novel technologies and clinical therapies to combat heart disease," said Rob Schwartz, MD, the Foundation's Medical Director of Education.

The entire conference schedule can be found here:

Schedule of Events (All times are ET; all events are held at the Miami Convention Center.)

Monday October 22

Core Training Curriculum in Clinical Research

How to Establish a Viable Clinical Research Program in Your Hospital: Essential First Steps and Standards Timothy D. Henry presents at 8:15 AM in Room: A104-105. CABG vs. PCI Trials: The Heart Team at Work Joseph N. Cosico presents at 3:10 PM in Room: A104-105

Chronic Total Occlusions: Evolutionary Approaches

Interventionalist to Interventionalist Referral for PCI: A Viable Specialty Triage Mechanism or Zone of Repugnance? M. Nicholas Burke,11:25 AM in Room: B217-218 Strategies for Cardiovascular Repair: Stem Cells and Beyond

Gene Therapy for Peripheral Artery Disease: Status Update, Timothy D. Henry presents at 11:40 AM in Room: A101-102

Ixmyelocel-T for CHF: Results of Catheter-based Study, Timothy D. Henry presents at 3:20 PM in Room: A101-102

Tuesday October 23

Poster Abstract Sessions-STEMI/NSTEMI Room: Hall D

TCT-527. Contemporary Outcomes of ST-elevation Myocardial in Patients with Prior Bypass Graft Louis Kohl, Ross Garberich, Hannah Yang, David Hildebrandt, Timothy Henry

TCT-524. Does the Zwolle Percutaneous Coronary Intervention Risk Index Identify Low Risk ST-Elevation Myocardial Infarction Patients for Early Discharge? Craig Strauss, Ivan Chavez, Ross Garberich, Anna Griffin, Matthew DeMay, Timothy D. Henry

TCT-530. Predictors and Clinical Outcomes Related to Door-in Door-out Times Ross Garberich, Stephanie Rutten-Ramos, Anil Poulose, David Larson, Timothy D. Henry Aortic Valve Disease and TAVR

TCT-842. Embolic Particles Show Surprising Size Dependent Predilection for Cerebral vs. Peripheral Arteries: Results from Computational Fluid Dynamic Modeling, Shawn Shadden, Naohiko Nemoto, Wesley Pedersen, John Lesser, Robert Schwartz

Challenging Case Session I: Best Cases

Endovascular repair of descending thoracic aortic pseudo-aneurysm in a patient with Loeys-Dietz II syndrome Ankur Kalra, Peter Alden, Kevin Harris, 8:00 AM - 10:00 AM in Room: Hall D

Peripartum acute ST-elevation myocardial infarction from spontaneous coronary artery dissection Ankur Kalra, Jay Traverse, 8:00 AM - 10:00 AM in Room: Hall D

Adjunct Imaging and Physiology

Use of IVUS reduces stent thrombosis: Results from the prospective, multicenter ADAPT-DES study, Timothy Henry presents at 10:30 AM - 12:30 PM in Room: D239

Transcatheter Aortic Valve Replacement I

Transcatheter Aortic Valve Replacement I, Oral Abstract Moderator, Wes Pedersen presents at 10:30 AM - 12:30 PM, Room: D237-238

Interventional Heart Failure

Cellular and Noncellular Implants for Heart Failure

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress Timothy D. Henry presents at 5:30PM - 6:10PM in Room: B210-211

Next-Generation DES and Bioabsorbable Scaffolds

The Potential for Novel Technologies, Robert S. Schwartz presents at 1:00 PM - 6:07 PM in Hall A-Coronary Theater

Noninvasive Imaging to Identify the High-Risk Patient and Plaque, Robert S. Schwartz presents at 1:00 PM - 6:07 PM in Hall A-Coronary Theater

Wednesday, October 24

Next-Generation Transcatheter Mitral Valve Therapies

Coronary Sinus Mitral Annuloplasty, Wesley R. Pedersen presents at 8:36 AM - 9:16 AM in Room: A201-202

Deep Dive: Stroke Prevention Therapies

Session IV. Flash Debates in Cardioembolic Therapies, Robert S. Schwartz presents at 8:00 AM-12:00 PM in Room A101-102

Plenary Session X.

Live Cases III, Michael Mooney, 8:00 AM-6:00 PM, Hall D

Deep Dive: Hypertension and Renal Artery Denervation- Renal Denervation: Rationale and Preclinical Science, Robert S. Schwartz presents at 2:00 PM-6:26 PM, Room A201-202

Thursday, October 25

Primary PCI for STEMI: Drugs, Devices, and Technique Controversies

Procedural Management Choices for Infarct Size Reduction

Hypothermia in STEMI: When, to Whom, and How? (Cardiac Arrest, Cardiogenic Shock, Stable STEMI) Michael Mooney presents at 11:33 AM in Room: A201-202

Plenary Session XIV

Game-Changing Therapies II. Is Interventional Heart Failure the Next Big Breakthrough? Timothy D. Henry presents at 10:15 AM - 11:00 AM in Room: Hall D

Friday, October 26

Intraaortic Balloon Counterpulsation for Percutaneous Aortic Valve or Complex PCI Procedures: Award Winning Case Presentations

Peripartum Acute ST-Elevation Myocardial Infarction from Spontaneous Coronary Artery Dissection Ankur Kalra presents at 7:00 AM, Room: C225-226

Plenary Session XXVIII

Masters Series. Wesley R. Pedersen presents at 1:00 PM - 3:15 PM, Room: Hall D


About the Minneapolis Heart Institute Foundation

The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.

  • Scientific Innovation and Research - Publishing more than 120 peer-reviewed studies each year, MHIF is a recognized research leader in the broadest range of cardiovascular medicine. Each year, cardiologists and hospitals around the world adopt MHIF protocols to save lives and improve patient care.
  • Education and Outreach - Research shows that modifying specific health behaviors can significantly reduce the risk of developing heart disease. Through community programs, screenings and presentations, MHIF educates people of all walks of life about heart health. The goal of the Foundation's community outreach is to increase personal awareness of risk factors and provide the tools necessary to help people pursue heart- healthy lifestyles.

About the Minneapolis Heart Institute®

The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.


Steve Goodyear
Minneapolis Heart Institute Foundation

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.